Standard Operating Procedure for Preparing Stability Reports for ANDAs

1) Purpose

The purpose of this SOP is to provide a standardized procedure for developing stability study reports for Abbreviated New Drug Applications (ANDAs) to the US FDA, ensuring compliance with regulatory requirements.

2) Scope

This SOP applies to all stability studies conducted in support of ANDA submissions. It is relevant to departments involved in regulatory affairs, quality control, and quality assurance.

3) Responsibilities

• Regulatory Affairs Team: Compiles and submits stability study reports for ANDA submissions.
• Quality Assurance (QA) Team: Reviews and approves stability study reports.
• Quality Control (QC) Team: Provides validated stability data for inclusion in reports.

4) Procedure

1. Data Compilation
   1. Gather all stability data, including test results, storage conditions, and time points.
   2. Ensure data complies with FDA requirements for ANDA submissions.
2. Report Preparation
   1. Prepare stability study reports, including all relevant data, analyses, and interpretations.
   2. Format the report according to FDA guidelines for
      

      Formulation Characterization and Stability of Protein Drugs

      ANDA submissions.
3. Submission Preparation
   1. Compile the stability documentation as part of the ANDA package.
   2. Submit the package to the Regulatory Affairs team for final review and submission to the FDA.

5) Abbreviations, if any

• ANDA: Abbreviated New Drug Application
• QC: Quality Control
• QA: Quality Assurance
• FDA: Food and Drug Administration

6) Documents, if any

• Stability Data Package
• Stability Report for ANDA Submission

7)